Evidence map›Paper›PMID 40977073›Full record

ArticleAngewandte Chemie (International ed. in English)2025

Dissimilar Reactions and Enzymes for Psilocybin Biosynthesis in Inocybe and Psilocybe Mushrooms.

Tim Schäfer, Fabian Haun, Bernhard Rupp, Dirk Hoffmeister

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Anthracaurisin A─Discovery of a CytotoxicJournal of natural products · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tim SchäferPharmaceutical Microbiology, Friedrich Schiller University, Winzerlaer Str. 2, 07745, Jena, Germany.
Fabian HaunPharmaceutical Microbiology, Friedrich Schiller University, Winzerlaer Str. 2, 07745, Jena, Germany.
Bernhard RuppDepartment of General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innrain 82, 6020, Innsbruck, Austria.ORCID 0000-0002-3300-6965
Dirk HoffmeisterPharmaceutical Microbiology, Friedrich Schiller University, Winzerlaer Str. 2, 07745, Jena, Germany.ORCID 0000-0002-5302-6461

Funding

Austrian Science Fund 10.55776/I5192Deutsche Forschungsgemeinschaft HO2515/11-1DFG Collaborative Research Center SFB 1127 239748522Germany´s Excellence Strategy 390713860Germany´s Excellence Strategy EXC 2051
6 · The paper itself

Abstract

Psilocybin (4-phosphoryloxy-N,N-dimethyltryptamine, 1) is the main indolethyl-amine natural product of psychotropic (so-called "magic") mushrooms. The majority of 1-producing species belongs to the eponymous genus Psilocybe, for which the biosynthetic events, beginning from l-tryptophan (2), and the involved enzymes have thoroughly been characterized. Some Inocybe (fiber cap) species, among them Inocybe corydalina, produce 1 as well. In product formation assays, we characterized four recombinantly produced biosynthesis enzymes of this species in vitro: IpsD, a pyridoxal-5'-phosphate-dependent l-tryptophan decarboxylase, the kinase IpsK, and two near-identical methyltransferases, IpsM1 and IpsM2. The fifth enzyme, the insoluble monooxygenase IpsH, was analyzed in silico. Surprisingly, none of the reactions intrinsic to the 1 pathway in Psilocybe species takes place in I. corydalina. Contrasting the situation in Psilocybe, the Inocybe pathway is branched and leads to baeocystin (4-phosphoryloxy-N-methyltryptamine, 3) as a second end product. Our results demonstrate that mushrooms recruited distantly or entirely unrelated enzymes to evolve the metabolic capacity for 1 biosynthesis twice independently.

Indexed as

AgaricalesPsilocybePsilocybinMethyltransferasesMethyltransferasesPsilocybinDecarboxylaseInocybeKinaseMethyltransferasePsilocybin

Identifiers

PMID40977073
PMCPMC12603985

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.